ReviewStem cell reviews and reports2026
Current Translational 3D In Vitro Models of Human Placental Tissue.
Review in Stem cell reviews and reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cellular models of placental tissue have the potential to recapitulate normal physiology, model disease, and facilitate therapeutic drug testing. In vivo or two-dimensional (2D) in vitro models of placental conditions have not been sufficiently representative of whole human tissue, thus have limited physiological relevance. This can be attributed to interspecies differences in placental physiology or a lack of structural complexity. In comparison, three-dimensional (3D) multicellular model systems provide a more sophisticated analogue of human placental tissue. Newer models of human placenta include 3D organoids, placenta-on-a-chip and organoid-on-a-chip, employing a range of materials and methods including pluripotent or trophoblast stem cells, microfluidics and 3D bioprinting. Accurately mimicking in vivo human tissue is crucial to the success of these translational 3D models of the placenta.In turn, a reliable representation of placental tissue architecture will allow discovery of the mechanisms underlying abnormal placental development and inform the prevention, diagnosis and treatment of pregnancy-related disorders such as preeclampsia and fetal growth restriction. Here, we provide a comprehensive critical appraisal of recent advances in 3D placental models, which aim to elucidate placental physiology, development and dysfunction. Additionally, we discuss how these platforms can accelerate the development of better monitoring and treatment strategies for pregnancy complications induced by a dysfunctional placenta.
Indexed as
Identifiers
42728540What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.